Get started
Author

Louise Schmidt

Observed name: L. Schmidt
ORCID: 0000-0001-6062-7065
Observed ORCID: 0000-0001-6062-7065
OpenAlex ID: A5091303247
EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?
2021 · L. Schmidt, O. Sehic, et al. · Journal of Pharmaceutical Policy and Practice · 27
PDF
Counting the cost of public and philanthropic R&D funding: the case of olaparib
2022 · L. Schmidt, O. Sehic, et al. · Journal of Pharmaceutical Policy and Practice · 11
PDF
Assessing the Public and Philanthropic Financial Contribution to the Development of New Drugs: A Bibliographic Analysis
2020 · Louise Schmidt, Claudia Wild · Science Technology & Public Policy · 9
PDF
Public contributions to R&D of medical innovations: A framework for analysis
2024 · Claudia Wild, Ozren Sehic, et al. · Health Policy · 8
‘Piloting a framework for analysing the public contributions to R&D: new antibiotics in focus’
2025 · Louise Schmidt, Ozren Sehic, et al. · Journal of Pharmaceutical Policy and Practice · 7
Public contributions to the development of antibiotics: two successful and two failed investments
2026 · Louise Schmidt, Ozren Sehic, et al. · Journal of Pharmaceutical Policy and Practice · 1
PDF
Public & philanthropic financial contribution to the development of new drugs: Methodology & 3 Case Studies
2019 · L. Schmidt, A. Prenner, et al.
Works count: 7
Citation count: 63
H-index: 5
I10-index: 2
Year
Topic
Type